Amer Sports, Inc.
ASAbout the company
Amer Sports, Inc. designs, manufactures, markets, distributes, and sells sports equipment, apparel, footwear, and accessories in Europe, the Middle East, Africa, the Americas, Mainland China, Hong Kong, Macau, Taiwan, and the Asia Pacific. It operates through three segments: Technical Apparel, Outdoor Performance, and Ball & Racquet Sports.
Investment snapshot
Positive
2
BUY / PASS
Neutral / negative
2 / 11
NEUTRAL / FAIL
Median fair value
$12.97
-52.4% vs price
Models with upside
1 / 16
Positive margin of safety
Strongest signal
8 of 11 pass — Lynch, Schloss and Dreman object
Key risk
No clean pass — all 12 investors flag at least one valuation criterion
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
| Metric | O'Shaughnessy Systematic Factor Composite | Lynch GARP | Buffett Quality Compounder | Pabrai Dhandho Framework | Akre Three-Legged Stool | Schloss Asset-Value Discipline | Neff Low-P/E Total Return | Sleep Scale Economies Shared | Templeton Global Bargain Hunter | Marks Risk-Aware Value | Munger Quality Focus | Ackman Activist Value | Dreman Contrarian Value | Piotroski F-Score | Greenblatt Magic Formula | Graham Defensive Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | NEUTRAL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | FAIL | PASS | FAIL | FAIL | PASS | FAIL | NEUTRAL | FAIL · Rank #771 (Top 24%) | FAIL |
| Score | ||||||||||||||||
| Analysis | ||||||||||||||||
| Intrinsic Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||
| Margin of Safety | N/A | N/A | -116.0% | -38.7% | -291.9% | N/A | N/A | N/A | N/A | N/A | -24.0% | +17.4% | -1413.3% | N/A | -290.8% | -104.2% |
| Data As Of | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-25) | 10-K (2026-08-24) | 10-K (2026-08-24) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) | 10-K (2026-08-23) |
Where It Passes
- Debt & Leverage73% pass✓ 11✗ 3▾
8 of 11 pass — Lynch, Schloss and Dreman object
Total Debt / Equity0.14✓Lynch< 0.33Cash - Long-term Debt$-140.0M✗LynchPositive preferredDebt/Equity & Interest CoverageD/E: 0.14, IC: 7.2x✓BuffettD/E < 0.5 AND Interest Coverage > 5xDebt Levels0.14✓AkreDebt/Equity < 0.3✓MungerDebt/Equity < 0.5Total Debt / Shareholders' Equity0.14x✓SchlossD/E < 1.00x✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓Dreman< 0.8Current Assets / Current Liabilities1.50x✗SchlossCurrent ratio >= 1.50x (app cutoff)✗Dreman> 1.5Interest Coverage & Debt/EBITDAIC=7.2x, D/EBITDA=0.7x✓MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.14✓Ackman<= 1.0LT Debt / Total Assets Change9.42% -> 7.87%✓PiotroskiDecreased YoYLT Debt vs Net Current AssetsLT Debt $792.3M vs NCA $1.1B✓GrahamLT Debt <= Net Current Assets - Cash Flow60% pass✓ 7✗ 5▾
6 of 10 pass — Oshaughnessy, Pabrai, Ackman +1 more object
(Operating cash flow - capex) / market capitalization+3.38%; #1858/4487 (top 41.4%)✗OshaughnessyTop 10% of eligible cross-sectionFCF Positive and Growing$513.3M✓LynchPositive and growingFree Cash Flow Proxy$595.1M✓BuffettPositive and growingP/E or FCF YieldP/E=35.8x, FCF Yield=3.4%✗PabraiP/E < 15 or FCF Yield > 10%Operating Cash Flow - Capital Expenditures$513.3M✓Neff> $0 (app proxy for a strong fundamental case)Positive Operating Cash Flow frequency4/5 years positive✓SleepPositive OCF in >= 70% of available yearsFCF Positive4/5 years FCF positive✓MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap3.4%✗Ackman>= 4%Price / FCF per Share29.6x✗Ackman<= 25Price / (CFO / Shares)20.8x✗Dreman< 8xOperating Cash Flow$729.8M✓PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=7.25%, ROA=4.25%✓PiotroskiCFO/Assets > ROA
Where It Falls Short
- Valuation0% pass✓ 2✗ 24▾
No clean pass — all 12 investors flag at least one valuation criterion
Revenue / market capitalization+0.4322; #2684/5203 (top 51.6%)✗OshaughnessyTop 10% of eligible cross-sectionNet income / market capitalization+2.81%; #2286/6251 (top 36.6%)✗OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization+3.38%; #1858/4487 (top 41.4%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-17.25%; #4404/6203 (top 71.0%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)P/E 35.8x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)P/E or FCF YieldP/E=35.8x, FCF Yield=3.4%✗PabraiP/E < 15 or FCF Yield > 10%Price / Book Value per Share2.62x✗SchlossP/B <= 0.80x (app cutoff)✗Templeton< 1.5x✗Dreman< 1.2xPrice / Tangible Book Value per Share22.28x✗SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+10395.2%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Price / Diluted EPS35.8x✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / EPS35.8x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)✗Dreman< 12xPrice vs. Trailing Low112% of trailing low ($24.25)✓Templeton<= 120% of trailing low (certified split-adjusted live window)P/B or P/E vs. Historical AverageP/E=35.8x, P/B=2.6x✗MarksP/E < 15 or P/B < 2.0Discount to Intrinsic Value-1413.3% (IV=$1.80 vs Price=$27.24)✗Marks>= 20% below intrinsic valueValuation ReasonablenessP/E=35.8x, OE Yield=3.9%✗MungerP/E < 25 or Owner Earnings Yield > 5%Price / FCF per Share29.6x✗Ackman<= 25Price / (CFO / Shares)20.8x✗Dreman< 8xEBIT / Enterprise Value4.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=4.6%, ROC=61.5%✗GreenblattBoth EY > 10% and ROC > 25%Price / 3-yr avg EPS227.0x✗Graham<= 15xPrice-to-Book Ratio2.6x✗Graham<= 1.5xP/E x P/B594.30✗Graham<= 22.5 - Profitability7% pass✓ 8✗ 23▾
14 of 15 flag AS's profitability — Oshaughnessy, Lynch, Buffett +11 more
Net income / market capitalization+2.81%; #2286/6251 (top 36.6%)✗OshaughnessyTop 10% of eligible cross-sectionBasic earnings-growth PEG (dividends excluded)P/E 35.8x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE7.4%✗Lynch> 15%Net Income Positive (10+ years)2/6 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-107.8%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)10.7% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$595.1M✓BuffettPositive and growingEarnings Variance (10-yr CoV)N/A (negative mean EPS)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdMargin of SafetyP/E=35.8x, P/B=2.6x✗PabraiP/B < 1.5 or P/E < 15Return on Equity-107.8% (3-yr avg)✗AkreROE > 20% (3-year avg)Positive Diluted-EPS Years2/5 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule)3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 52.5% -> 57.6%, operating margin 6.9% -> 10.7%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend6.9% (2023) -> 10.7% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsDiscount to Intrinsic Value-1413.3% (IV=$1.80 vs Price=$27.24)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency2/5 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue10.7%✗Ackman>= 15%Net Income / Shareholders Equity7.4%✗Ackman>= 15%Pre-Tax Income / Revenue9.5%✓Dreman>= 8%Net Income / Shareholders' Equity7.4%✗Dreman> 12%Net Income / Total Assets4.25%✓PiotroskiROA > 0ROA Change YoY0.86% -> 4.25% (delta: +3.38%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=7.25%, ROA=4.25%✓PiotroskiCFO/Assets > ROAGross Margin Change YoY55.4% -> 57.6%✓PiotroskiImproved YoYEBIT / Enterprise Value4.6%✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=4.6%, ROC=61.5%✗GreenblattBoth EY > 10% and ROC > 25%Positive EPS (10 years)2/6 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growth - Growth13% pass✓ 3✗ 10▾
7 of 8 flag AS's growth — Lynch, Neff, Sleep +4 more
Basic earnings-growth PEG (dividends excluded)P/E 35.8x (growth N/A)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: 32.6% vs Rev: 26.7%✗LynchInventory growth < Revenue growth3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedRevenue growth vs. gross and operating margin trendgross margin 52.5% -> 57.6%, operating margin 6.9% -> 10.7%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR✗SleepCAGR > 7%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Positive Net Income Frequency2/5 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth23.2%✓Ackman>= 5%Positive EPS Growth Frequency3/4 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 yearsEPS Growth Direction$-0.33 (2021) -> $0.76 (2025)✓DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growth - Efficiency13% pass✓ 2✗ 9▾
7 of 8 flag AS's efficiency — Buffett, Akre, Sleep +4 more
ROIC (3-5 yr avg)5.3%✗Buffett> 10%ROIC - WACC-4.7%✗BuffettPositive (WACC = 10%)ROIC (high and growing)FY2023: ROIC=3.9%; FY2024: ROIC=6.4%; FY2025: ROIC=8.4%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROIC8.4% (RR=100% x ROIC=8.4%)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/4 years above 12% (latest 8.4%)✗SleepROIC > 12% in a majority of yearsReturn on Invested Capital8.4%✗Munger> 15%Current Assets / Current Liabilities1.50✗Dreman> 1.5Current Ratio Change YoY1.52 -> 1.50✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY0.62x -> 0.65x✓PiotroskiImproved YoYEBIT / (NWC + Net Fixed Assets)61.5%✓Greenblatt> 25%Current Ratio1.50✗Graham>= 2.0 - Valuation models13% pass✓ 1✗ 7▾
Models split on AS at $27.24 — fair values range $1.80–$32.97
Buffett fair value$12.61✗Buffett-116.0% margin vs $27.24Pabrai fair value$19.64✗Pabrai-38.7% margin vs $27.24Akre fair value$6.95✗Akre-291.9% margin vs $27.24Munger fair value$21.96✗Munger-24.0% margin vs $27.24Ackman fair value$32.97✓Ackman+17.4% margin vs $27.24Dreman fair value$1.80✗Dreman-1413.3% margin vs $27.24Greenblatt fair value$6.97✗Greenblatt-290.8% margin vs $27.24Graham fair value$13.34✗Graham-104.2% margin vs $27.24 - Verdicts14% pass✓ 2✗ 12▾
Split decision: 11 FAIL · 2 NEUTRAL · 2 PASS
Overall verdict•OshaughnessyNEUTRAL (Not ranked)✗LynchFAIL (2/7)✗BuffettFAIL (3/9)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗SchlossFAIL (2/7)✗NeffFAIL (2/6)✗SleepFAIL (2/6)✓TempletonPASS (4/8)✗MarksFAIL (2/5)✗MungerFAIL (1/4)✓AckmanPASS (5/9)✗DremanFAIL (4/11)•PiotroskiNEUTRAL (F-Score 7)✗GreenblattRank #771✗GrahamFAIL (2/9)
Business & financials
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Issued 0.7% of shares last year, 10.4% issued over two.
- Buybacks
- —
- Dividends
- —
What drove EPS
A buyback raises earnings per share without the company earning more. This splits each year's change into the two.
The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.
Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.
Company Financials
Annual data (10-K) · Last 5 years
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $15.2B | $17.7Best. | $8.2Best. | -- | -- |
| Revenue | $6.6B↑27% | $5.2B↑18% | $4.4B↑23% | $3.6B↑16% | $3.1B |
| Operating Income | $701.8M↑49% | $470.8M↑56% | $302.5M↑498% | $50.6M↓73% | $186.9M |
| Net Income | $427.4M↑489% | $72.6M↑135% | -$208.6M↑17% | -$252.7M↓100% | -$126.3M |
| EPS (Diluted) | $0.76↑443% | $0.14↑126% | $-0.54↑18% | $-0.66↓100% | $-0.33 |
| Gross Margin | 57.6%↑4% | 55.4%↑6% | 52.5%↑5% | 50.0%↑2% | 49.1% |
| Operating Margin | 10.7%↑18% | 9.1%↑32% | 6.9%↑385% | 1.4%↓77% | 6.1% |
| ROE | 7.4%↑407% | 1.5%↓99% | 130.2%↓62% | 341.9%↑203% | -332.4% |
| Total Debt | $792.3M | $790.8M↓87% | $6.2B | $6.2B | -- |
| Shareholders' Equity | $5.8B↑16% | $5.0B↑3221% | -$160.2M↓117% | -$73.9M↓294% | $38.0M |
| Current Ratio | 1.50↓2% | 1.52↑2% | 1.49↓12% | 1.70 | — |
| Debt / Equity | 0.14↓14% | 0.16↑100% | -38.90↑54% | -84.38 | — |
| Operating Cash Flow | $729.8M↑72% | $424.7M↑113% | $199.0M↑317% | -$91.7M↓134% | $268.0M |
| Free Cash Flow | $513.3M↑162% | $195.6M↑159% | $75.4M↑145% | -$169.4M↓182% | $207.3M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Apparel
AS vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CINTAS CORPCTAS | $79.0B | $197.74 | $10.3B | $1.8B | 38.7% | 0.52 | 22.8% | 2.09 | 3/9 | 5/9 | 1/7 | 1/3 | F-Score 5 | 5/11 |
| TAPESTRY, INC.TPR | $22.8B | $114.12 | $7.0B | $183.2M | 21.4% | 2.79 | 5.9% | 1.87 | 1/9 | 3/9 | 1/7 | 0/3 | F-Score 5 | 3/11 |
| DECKERS OUTDOOR CORPDECK | $10.8B | $77.68 | $5.5B | $1.0B | 41.0% | — | 23.1% | 3.54 | 2/9 | 5/9 | 3/7 | 3/3 | F-Score 7 | 5/11 |
| lululemon athletica inc.LULU | $10.7B | $96.87 | $11.1B | $1.6B | 31.8% | 0.00 | 19.9% | 2.26 | 4/9 | 5/9 | 3/7 | 3/3 | F-Score 4 | 5/11 |
| On Holding AGONON | $9.9B | $29.55 | $3.8B | $257.3M | 12.5% | 0.32 | 12.5% | 2.71 | 2/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 4/11 |
| Gildan Activewear Inc.GIL | $7.9B | $42.62 | $3.6B | $398.9M | 11.2% | 1.21 | 17.1% | 2.11 | 3/9 | 5/9 | 1/7 | 0/3 | F-Score 4 | 5/11 |
| LEVI STRAUSS & COLEVI | $7.6B | $19.75 | $6.3B | $578.1M | 25.4% | 0.46 | 10.8% | 1.55 | 3/9 | 5/9 | 2/7 | 1/3 | F-Score 7 | 5/11 |
| Crocs, Inc.CROX | $6.3B | $126.14 | $4.0B | $81.2M | -6.3% | 0.95 | 3.7% | 1.27 | 2/9 | 4/9 | 0/7 | 1/3 | F-Score 5 | 2/11 |